Corgenix Medical

Corgenix, VHFC receive $2.9M NIH grant to develop Ebola rapid diagnostic test kit

Friday, June 27, 2014

Corgenix Medical, a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million NIH grant to advance the development of an Ebola rapid diagnostic test kit. Collaborating with Corgenix on the program will be members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University and partially funded by the NIH.

[Read More]